Serina Therapeutics's total assets for Q2 2026 were $25.81M, a decrease of -5.44% from the previous quarter. DE:2BO total liabilities were $7.08M for the fiscal quarter, a -26.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.